Volume 52, Number 10, October2007

  Editorial
869 " align="left" valign="top" class="tocTitle">
 
Lawrence D. Devoe, M.D.
 
   
  Brief Communication
871 " align="left" valign="top" class="tocTitle">
 
Brittany B. Rayburn, William F. Rayburn, M.D., Chen Meng, M.S., and Nancy S. Handmaker, Ph.D.
Hazardous drinkers were inclined to drink wine with other alcoholic beverages yet tended to abstain or minimize consumption after pregnancy recognition.
 
 


  Original Articles
874
James Fanning, D.O., Lori Larrick, M.S., Louis Weinstein, M.D., Terrence J. Horrigan, M.D., Michael P. Marcotte, M.D., and Robert F. Flora, M.D.
Competitive running before the perimenopausal period is associated with improved hip bone mineral density, but continued competitive running is not associated with prevention of perimenopausal hip bone mineral density decline.
 
 


879
Ibrahim V. Fenkci, M.D., Mustafa Serteser, M.D., Semin Fenkci, M.D., and Songul Kose, M.D.
Decreased paraoxonase activity might contribute to an increased propensity for the development of cardiovascular disease in women with polycystic ovary syndrome.
 
 


884
Shad H. Deering, M.D., Jessica Zaret, M.D., Kristen McGaha, B.S.N., and Andrew J. Satin, M.D.
Patients with birth plans have the same cesarean section and episiotomy rate as matched controls without birth plans, but are less likely to receive an epidural in labor.
 
 


888
Stephen D. Silberstein, M.D., and Jay Goldberg, M.D., M.S.C.P.
Management of menstrual migraine can reduce disability among women of childbearing age; triptans are safe and effective in acute and prophylactic treatment of menstrual migraine.
 
 


896
Valerie S. Ratts, M.D., Rachel N. Pauls, M.D., Anil B. Pinto, M.D., Aldi Kraja, Daniel B. Williams, M.D., and Randall R. Odem, M.D.
Our data provide another reason, achievement of a singleton pregnancy, to support the routine use of metformin for ovulation induction in polycystic ovary syndrome patients who are resistant to clomiphene citrate: a reduction in the risk of multiple gestation.
 
 


901
LCDR David M. Haas, MC, USN, and LCDR Lisa A. Pazdernik, MC, USN
Pregnant servicewomen, women with partners deployed in the military, those with multiple children and those without support are at high risk of reporting increased stress levels.
 
 


907
Mark F. Sewell, M.D., Larraine Huston-Presley, M.S., Saeid B. Amini, J.D., M.B.A., Ph.D., and Patrick M. Catalano, M.D.
Body mass index correlates significantly with estimates of maternal obesity during pregnancy.
 
 


912
Neha Kamdar, M.D., Laura Fisher, M.D., and Colin MacNeill, M.D.
Montelukast resulted in an average improvement of 52% in the vestibular pain score, and, in a subgroup, the improvement was >75%.
 
 


917
Maj Scott Petersen, MC, LtCol Christina Belnap, MC, Col Wilma I. Larsen, MC, and LtCol John Farley, MC
Since graded mild endocervical dysplasia has a minimal increased risk of progressing to severe dysplasia on subsequent loop electrical excision procedure specimens, these patients can be offered conservative follow-up with colposcopy rather than initial definitive therapy.
 
 


922
Michael L. Power, Ph.D., Lauren A. Milligan, M.A., and Jay Schulkin, Ph.D.
Obstetrician-gynecologists' treatment of nausea and vomiting of pregnancy generally follows American College of Obstetricians and Gynecologists recommendations, but respondents who read the organization's practice bulletin on the topic were more willing to treat aggressively.
 
 


929
Byron C. Calhoun, M.D., M.B.A., Elizabeth Shadigian, M.D., and Brent Rooney, B.Sc.
Induced abortion contributes to significantly increased initial neonatal health costs, >$1.2 billion, and 1,096 excess cerebral palsy cases per year in the United States.
 
 


938
Dah-Ching Ding, M.D., Senzan Hsu, M.D., Sidney S. Chen, M.D., and Yung-Hsiang Hsu, M.D.
A high rate of cervical dysplasia in the reactive cellular changes group, Bethesda 3 system, was found.
 
 


941
Xirun Wan, M.D., Yang Xiang, M.D., Xiuyu Yang, M.D., Yu Wu, M.D., Ning Liu, M.D., Ling Chen, M.D., and Ruofan Dong, M.D.
The cure rate was 63.6%, which is equivalent to the efficacy of most regimens for the treatment of high-risk, drug-resistant gestational trophoblastic tumor.
 
 


945
Fabio Facchinetti, M.D., Paolo Venturini, M.D., Marta Fazzio, M.D., and Annibale Volpe, M.D.
The dinoprostone slow-release vaginal insert is the first choice for elective induction of labor in prolonged pregnancy.
 
 


  Case Reports
950
Adelina M. Emmi, M.D., Lawrence D. Devoe, M.D., Daksha B. Chudgar, M.D., Erin Holsten, M.D., and Lawrence C. Layman, M.D.
A 36-year-old in vitro fertilization patient was successfully treated for a cervical pregnancy with only medical management.
 
 


953
Sven Becker, M.D., Erich Solomayer, M.D., Susanne Mackensen-Haen, M.D., Diethelm Wallwiener, M.D., and Tanja Fehm, M.D.
A case of acute twin-twin transfusion syndrome occurred in a previously asymptomatic, monochorionic, diamniotic twin pregnancy with the mother hospitalized for preterm labor.
 
 


956
Dah-Ching Ding, M.D., and Senzan Hsu, M.D.
Lipid cell tumor of the ovary in an adolescent girl was associated with amenorrhea and virilization.
 
 


959
Alexandros Rodolakis, M.D., Nikolaos Thomakos, M.D., Nicholas Harhalakis, M.D., Thomais Iconomou, M.D., and Aris Antsaklis, M.D.
Vaginal stenosis developed in a woman with chronic myeloid leukemia as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
 
 


962
Takashi Murakami, M.D., Ph.D., Hitoshi Niikura, M.D., Ph.D., Yuki Shima, M.D., Ph.D., Yukihiro Terada, M.D., Ph.D., and Kunihiro Okamura, M.D., Ph.D.
The shallow intramural cervical myoma had to be sloughed off after cesarean section.
 
 


965
Hisato Koshiba, M.D., Ph.D.
A case of chemical peritonitis was caused by an ovarian cyst rupture, lasted 1 year and required immunosuppressive drugs.
 
 


968
Liron Pantanowitz, M.D., Michel Prefontaine, M.D., and John P. Hunt, M.D.
Cholelithiasis of the ovary is a rare finding and may occur when gallstones are dropped into the pelvis during laparoscopic cholecystectomy.
 
 


971
John P. Micha, M.D., Bram H. Goldstein, Ph.D., Douglas Zusman, M.D., Mark A. Rettenmaier, M.D., Howard D. Epstein, M.D., and John V. Brown III, M.D.
Although our results are only preliminary, our patient's initial improvement in outcome warrants additional investigation of the drug's potential efficacy as treatment for malignant pericardial effusion.
 
 


974
Joost J. Zwart, M.D., Hans C. M. van Huisseling, M.D., Herman M. Schuttevaer, M.D., Jos van Roosmalen, M.D., and Dick Oepkes, M.D.
Obstetricians should be aware of the risk of abnormal placentation in women who have undergone dilatation and curettage, as it could lead to a life-threatening obstetric hemorrhage.
 
 


977
Manisha Palep-Singh, M.D., MRCOG, Jay Jayaprakasan, MBBS, MRCOG, and James F. Hopkisson, M.D., MRCOG
Aggressive management of group A streptococcal infection in the peripartum period can prevent life threatening morbidity.
 
 


979
Sarah E. Stilwill, B.A., and Brian C. Cooper, M.D.
A postmenopausal woman with endometrial hyperplasia and breast cancer experienced resolution of the hyperplasia with adjuvant anastrozole therapy.
 
 


981
Fang-Ping Chen, M.D.
Conservative treatment for spontaneous rupture of the uterus before fetal maturity may be considered as an alternative to hysterectomy.
 
 


  Letter to the Editors
984
William A. Alto, M.D., and Cornelius A. Yetman, D.O.